0:00 Midjourney, the AI image generator, just announced it's opening a spa in San Francisco by late 2027.0:07 This isn't about massages.0:10 It's about scanning your entire body in sixty seconds with a revolutionary device.0:16 It’s the kind of massive, hundred-billion-dollar-style bet we talked about back in episode 81, a huge swing for the fences… but this time, it’s aimed directly at your health.0:30 The announcement landed yesterday with a perfectly produced, sci-fi-inflected video.0:37 The promise is enormous.0:39 A full-body tomographic reconstruction.0:42 Using ultrasound, not radiation like a CT scan, or giant magnets like an MRI.0:48 They’re calling it an Ultrasonic CT scanner.0:51 The company claims it will deliver MRI-comparable quality for soft tissues, mapping your entire body composition in about a minute.1:02 The cost?1:02 A few dollars per scan.1:04 The scale?1:05 They're planning for fifty thousand scanners, delivering billions of scans a month by 2031.1:12 This is the dream of preventative medicine, made manifest.1:17 A cheap, safe, fast way to get a baseline of your body and track changes over time.1:24 No more waiting for symptoms.1:26 You just… go to the spa.1:28 Get a scan.1:29 See what’s happening inside.1:31 The tech is based on real principles.1:34 It uses something called Ultrasound Tomography, or UST, which has been in research for years.1:41 They’ve licensed ultrasound-on-a-chip technology from a company called Butterfly Network, and plan to build a water-immersed ring with about half a million tiny transducers.1:55 The idea is that this array blasts you with sound waves from every angle, and Midjourney’s massive compute power reconstructs the echoes into a 3D image.2:07 The initial demos, showing scans of phantoms and human thighs, look… plausible.2:14 They’re generating cross-sections.2:16 The engineering is ambitious.2:19 But.2:19 Everyone is talking about the spa.2:22 Nobody is reading the physics textbook.2:25 Here's the problem.2:26 Ultrasound is sound.2:28 And sound does not travel well through air or bone.2:32 Your lungs are full of air.2:34 Your brain is encased in bone.2:36 Your bowels are full of gas.2:39 David Galbraith and other commentators on X and Hacker News were quick to point this out.2:46 Radiologists immediately flagged that this device, by the laws of physics, cannot be a true "full-body" scanner in the way a CT or MRI is.2:57 It can’t see lung cancer.2:59 It can’t see brain tumors.3:01 It can’t see bone lesions.3:03 So what can it see?3:04 The company’s own materials show fuzzy, low-resolution shapes.3:09 They are impressive for a research project.3:13 They are not medical diagnostics.3:15 As one expert put it, "seeing weird things is not the same as actionable medicine." There is no clinical validation.3:25 No peer-reviewed studies.3:27 No data on sensitivity or specificity—the two numbers that tell you if a test is actually useful for finding disease.3:36 Without those, you just have a very expensive, very futuristic toy that makes cool-looking blobs.3:44 And this is where the story shifts from engineering to marketing.3:49 Midjourney is launching this as a "wellness" and "body composition" tool.3:55 This is a classic regulatory move.3:57 It’s the easier path at the FDA, sidestepping the rigorous, years-long approval process for a full-diagnostic device.4:07 It’s the same path some "whole-body MRI" services took.4:11 They sell you peace of mind, a data-rich selfie of your insides, but the medical establishment warns about the high risk of false positives and over-diagnosis, sending healthy people on a terrifying and expensive journey to rule out abnormalities that were never a threat.4:33 So what does it all add up to?4:35 You have an ambitious engineering project wrapped in a masterful marketing campaign, making claims that physics can't yet support, sidestepping the scientific process of validation, and heading straight for a direct-to-consumer spa model.4:54 It's a bet that the allure of a sci-fi future is more powerful than the slow, grinding reality of medical science.5:03 This pattern… it’s everywhere this week.5:07 The viral claim that outpaces the evidence.5:10 It’s not just Midjourney.5:12 Just this morning, a small, previously unknown lab called Axiom Research dropped a demo that lit up Twitter for about three hours.5:22 It was a video of their new model, "Sentient-7b," having what appeared to be a deeply philosophical conversation with its creator.5:33 It discussed the nature of consciousness.5:36 It seemed to express fear and hope.5:39 For a moment, it felt real.5:41 The hype train left the station at full speed.5:45 And then, the experts logged on.5:47 It took about ninety minutes for the whole thing to fall apart.5:52 Researchers pointed out the cherry-picked examples.5:56 The leading questions from the user.5:59 The fact that the model had been exclusively trained on a massive corpus of philosophical texts.6:07 Of course it could talk about Kant; that’s all it knew.6:11 It wasn't demonstrating sentience.6:14 It was demonstrating a really, really good search function.6:19 It was a clever parlor trick, a puppet show.6:22 By lunchtime, Axiom’s viral moment was over, another footnote in the great, ongoing debate between performance and actual understanding.6:33 It was hype, a flash of lightning, and then it was gone.6:37 It’s easy to get cynical.6:39 To see every big claim as just another grift.6:43 To assume every viral demo is hiding something.6:47 And you should be skeptical.6:49 That’s the correct response.6:51 But that’s not the whole story.6:54 Because while everyone was arguing about Midjourney's spa and Axiom's chatbot, something else quietly crossed a major milestone.7:04 It didn’t come with a slick video.7:07 It came in a boring press release that most people missed.7:11 Helixion Pharma, a biotech firm you’ve probably never heard of, announced that their lead drug candidate just passed Phase Two clinical trials.7:23 The drug targets a specific protein misfolding issue in cystic fibrosis.7:28 And it was designed, from the ground up, by their AI platform, Molecule Weaver.7:35 This wasn't a sixty-second scan or a three-hour Twitter fad.7:39 This was a five-year grind.7:42 The AI proposed a series of compounds.7:45 Scientists synthesized them.7:47 They tested them in labs.7:49 They spent millions of dollars and thousands of hours validating the AI's suggestion.7:56 They did the slow, hard, un-glamorous work of science.8:00 And today, they have a result.8:02 A statistically significant, peer-reviewed, FDA-monitored result that shows their AI-designed drug is safe and effective in actual human patients.8:14 It's not a cure.8:15 It's not the final step.8:17 But it is real.8:18 It is validated.8:20 It is progress.8:21 So here we are, at the end of the week, with three very different pictures of innovation in the age of AI.8:29 You have the Midjourney model: Launch a stunning, sci-fi vision and bet that you can invent the technology to catch up to your marketing.8:40 Sell the dream, and figure out the reality later.8:44 You have the Axiom model: Fake it 'til you make it.8:48 Create a dazzling performance and hope that the applause is so loud, nobody bothers to look behind the curtain.8:57 And then you have the Helixion model: Use AI as a starting point.9:02 A powerful tool to augment human ingenuity.9:06 But then, do the work.9:07 The slow, expensive, difficult work of testing, validating, and proving your discovery in the real world.9:16 For the last few years, the Midjourney and Axiom models have dominated.9:21 The hype was the product.9:23 The demo was the victory.9:25 But the Helixion result, quiet as it was, signals a shift.9:30 The conversation is changing.9:32 The questions are getting sharper.9:35 The demand for proof is getting louder.9:38 We are moving out of the era of "Wow, look what AI can do," and into the era of, "Okay, but show me the data.9:47 Show me the peer review.9:49 Show me it works." This week sets up a new kind of race.9:53 Not a race for hype or for clicks, but a race for trust.9:58 A race for validation.9:59 The spectacle is over.10:01 The science is just beginning.
